![Robert Fishman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Fishman
Keine laufenden Positionen mehr
Profil
Robert Stephen Fishman worked as Director-Clinical Affairs at Heartport, Inc. from 1995 to 1998.
He then worked as Vice President-Scientific Affairs at Aerogen, Inc. from 1998 to 2005.
From 2005 to 2007, he was Senior Vice President-Clinical Development at Anthera Pharmaceuticals, Inc. He then worked as Vice President-Medical Affairs at Alexza Pharmaceuticals, Inc. from 2007 to 2009.
From 2012 to 2015, he was Senior Vice President-Clinical Development at InterMune, Inc. He worked as Chief Medical Officer at Corcept Therapeutics, Inc. from 2015 to 2019.
He also served as a Trustee at Boca Raton Regional Hospital, Inc. He is currently working as Chief Medical Officer at 4D Molecular Therapeutics, Inc. from 2020 to 2023.
He previously worked as Chief Medical Officer at Xoc Pharmaceuticals, Inc. from 2019 to 2020.
Dr. Fishman received his undergraduate degree from Harvard University and his doctorate from Stanford University School of Medicine.
Ehemalige bekannte Positionen von Robert Fishman
| Unternehmen | Position | Ende |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 13.04.2023 |
Xoc Pharmaceuticals, Inc.
 Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel oral therapies for migraine prevention and dopamine agonism parkinson’s disease management | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2020 |
| CORCEPT THERAPEUTICS INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 31.01.2019 |
| INTERMUNE INC | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2015 |
| ANTHERA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 |
Ausbildung von Robert Fishman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
51
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Heartport, Inc.
 Heartport, Inc. Medical SpecialtiesHealth Technology Develops systems and procedures for heart surgery | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Aerogen, Inc.
 Aerogen, Inc. Medical SpecialtiesHealth Technology Develops and manufactures aerosol products | Health Technology |
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
Anthera Pharmaceuticals, Inc.
 Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boca Raton Regional Hospital, Inc.
 Boca Raton Regional Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Xoc Pharmaceuticals, Inc.
Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel oral therapies for migraine prevention and dopamine agonism parkinson’s disease management | Commercial Services |
